InsiderClue
← All stocks

BIOMARIN PHARMACEUTICAL INC

BMRN Net selling
CIK 0001048477 #822 in the set updated 17 Sep 2026
Bought (120 mo)
$1.32M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$287.10M
$5.28M on a plan · $231.37M straight out of an exercise
Sold at will
$50.45M
123 of 378 sales
Net
−$285.78M
−$49.14M against sales at will

By person

32 insiders · 421 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BIENAIME JEAN JACQUES
Director
—
$162.33M (173) scheduled
−$162.33M
473,892
0.2448%
$31.41M
+371.8%
FUCHS HENRY J
President, Worldwide R&D
—
$41.37M (27) scheduled
−$41.37M
185,074
0.0956%
$12.27M
+65.5%
Davis George Eric
EVP, Chief Legal Officer
—
$29.02M (36) scheduled
−$29.02M
61,003
0.0315%
$4.04M
−15.2%
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
—
$18.33M (48) scheduled
−$18.33M
66,767
0.0345%
$4.43M
+12.5%
SPIEGELMAN DANIEL K
EVP, Chief Financial Officer
—
$9.06M (11)
−$9.06M
47,686
0.0246%
$3.16M
−38.3%
LAWLIS V BRYAN
Director
—
$8.33M (21) scheduled
−$8.33M
33,140
0.0171%
$2.20M
+158.7%
Mueller Brian
EVP, Chief Financial Officer
—
$7.36M (24) scheduled
−$7.36M
123,314
0.0637%
$8.17M
+736.4%
Guyer Charles Greg
EVP, Chief Technical Officer
—
$2.95M (5)
−$2.95M
84,140
0.0435%
$5.58M
+9,560%
BAFFI ROBERT
President, Global Mfg/Tech Ops
—
$2.93M (5)
−$2.93M
189,020
0.0976%
$12.53M
+27.2%
MEIER RICHARD A
Director
—
$1.21M (6) scheduled
−$1.21M
127,426
0.0658%
$8.45M
+359.0%
LEWIS ALAN
Director
—
$1.16M (3) scheduled
−$1.16M
25,590
0.0132%
$1.70M
+34.6%
PYOTT DAVID E I
Director
$1.00M (2)
—
+$1.00M
49,750
0.0257%
$3.30M
+1,640%
GREY MICHAEL G
Director
—
$682.28K (2) scheduled
−$682.28K
42,840
0.0221%
$2.84M
+54.3%
Burkhart Erin
GVP, Chief Accounting Officer
—
$560.45K (5) scheduled
−$560.45K
14,173
0.0073%
$939.44K
—
Friberg Gregory R
EVP, Chief R&D Officer
—
$558.62K (2)
−$558.62K
51,818
0.0268%
$3.43M
+12,920%
Dere Willard H
Director
—
$547.59K (1)
−$547.59K
46,440
0.0240%
$3.08M
+1,659%
Slamon Dennis
Director
—
$501.01K (6)
−$501.01K
31,299
0.0162%
$2.07M
+299.5%
Alles Mark J
Director
$314.47K (1)
—
+$314.47K
15,095
0.0078%
$1.00M
—
HERON ELAINE J
Director
—
$168.05K (2)
−$168.05K
97,720
0.0505%
$6.48M
+163.1%
Hubbard Cristin
EVP, Chief Commercial Officer
—
$17.72K (1) scheduled
−$17.72K
42,472
0.0219%
$2.82M
+52,990%
Hardy Alexander
Chief Executive Officer
—
—
—
214,635
0.1109%
$14.23M
—
HOMBACH ROBERT J.
Director
—
—
—
49,360
0.0255%
$3.27M
—
ANDERSON ELIZABETH M
Director
—
—
—
41,940
0.0217%
$2.78M
—
Ho Maykin
Director
—
—
—
35,500
0.0183%
$2.35M
—
Ramchandani Rashmi Virendra
VP, Chief Accounting Officer
—
—
—
25,610
0.0132%
$1.70M
—
Bodem Barbara W.
Director
—
—
—
21,045
0.0109%
$1.39M
+420,800%
Enyedy Mark J
Director
—
—
—
21,040
0.0109%
$1.39M
—
Countouriotis Athena
Director
—
—
—
21,040
0.0109%
$1.39M
—
Acosta Andrea
GVP, Chief Accounting Officer
—
—
—
18,122
0.0094%
$1.20M
+20.3%
Walbert Timothy P
Director
—
—
—
17,270
0.0089%
$1.14M
—
CLARK IAN T
Director
—
—
—
14,490
0.0075%
$960.46K
—
Plenge Robert M
Director
—
—
—
6,140
0.0032%
$406.98K
—

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Burkhart Erin
20 May 2025
GVP, Chief Accounting Officer
Sold on a plan
1,786
$59.31
$105.93K
Hubbard Cristin
2 May 2025
EVP, Chief Commercial Officer
Sold on a plan
273
$64.92
$17.72K
Burkhart Erin
19 Mar 2025
GVP, Chief Accounting Officer
Sold on a plan
1,295
$71.52
$92.62K
Burkhart Erin
24 Feb 2025
GVP, Chief Accounting Officer
Sold on a plan
1,344
$68.38
$91.90K
Burkhart Erin
13 Aug 2024
GVP, Chief Accounting Officer
Sold on a plan
714
$90.00
$64.26K
Ajer Jeffrey Robert
2 May 2024
EVP, Chief Commercial Officer
Sold on a plan
5,000
$82.91
$414.55K
Burkhart Erin
10 Apr 2024
GVP, Chief Accounting Officer
Sold on a plan
2,286
$90.00
$205.74K
Davis George Eric
28 Mar 2024
EVP, Chief Legal Officer
Sold on a plan
24,602
$88.34
$2.17M
Ajer Jeffrey Robert
5 Mar 2024
EVP, Chief Commercial Officer
Sold on a plan
4,000
$87.07
$348.28K
Davis George Eric
13 Dec 2023
EVP, Chief Legal Officer
Sold on a plan
13,764
$95.30
$1.31M
Ajer Jeffrey Robert
16 Aug 2023
EVP, Chief Commercial Officer
Sold on a plan
5,000
$90.00
$450.00K
Showing 250 of 421 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 626
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 244
Sales at will 123
Transactions with no price 0
Shares from compensation/vesting 7,156,030
Sales filed before the plan box existed 107
History held since 30 Aug 2016